Atlas Trials

Lung Cancer Stage IV

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lung Cancer Stage IV

RecordFirmDate
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities (NCT05311709)Vestre Viken Hospital Trust2022-05-30
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs (NCT04519983)Shanghai Cancer Hospital, China2022-01-01
Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System (NCT06722885)Universitair Ziekenhuis Brussel2022-01-01
Resilience Measurement in Older Adults With Late-Stage Lung Cancer (NCT04825912)Duke University2021-05-03
Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion (NCT04669223)The University of Hong Kong2020-12-01
Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. (NCT04595734)Western Sydney Local Health District2020-01-07
Personalizing Immune Checkpoint Inhibitor Therapy (NCT03409341)Holy Cross Hospital, Maryland2019-02-01
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer (NCT03728361)Dwight Owen2018-12-31
A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC (NCT03668496)Jiangsu HengRui Medicine Co., Ltd.2018-11-09
Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients (NCT03529851)Regional Hospital West Jutland2018-05-01
Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay (NCT03558165)University Health Network, Toronto2018-03-01
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating (NCT03322072)CancerCare Manitoba2017-11-23
Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation (NCT03153358)Sichuan Cancer Hospital and Research Institute2017-06-02
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib (NCT03076164)Memorial Sloan Kettering Cancer Center2017-03-01

Track Lung Cancer Stage IV automatically

Every clearance here is in the API, with alerts when new ones post.